Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA methyltransferase subunit 11-2 pseudogene 8 (TRMT112P8) is a processed human pseudogene, corresponding to the functional TRMT112 gene (tRNA methyltransferase activator subunit 11-2), which plays a role as an activator of several tRNA methyltransferases required for tRNA and rRNA modification[1][3][5][6]. As a pseudogene, TRMT112P8 does not encode a functional protein and lacks known biological function, disease relevance, or drug interactions[1][5][6]. Unlike some pseudogenes that may have regulatory RNA roles, there is currently no evidence in the scientific literature or major databases that TRMT112P8 exhibits any biological activity or regulatory function[1][5][6]. Therefore, it is not considered a therapeutic target, biomarker, or subject to pharmacological intervention. Pseudogenes like TRMT112P8 are usually formed by genomic duplication or retrotransposition of a functional gene, but with mutations or lack of regulatory elements that preclude protein production[6]. Some pseudogenes have regulatory properties—such as acting as competing endogenous RNAs—but TRMT112P8 has not been demonstrated to do so[4][6]. TRMT112P8 is a non-coding pseudogene, not used as a therapeutic target, and should not be confused with the functional enzyme (TRMT112) that is involved in tRNA modification. There are no known biological, clinical, or pharmacological associations with TRMT112P8.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase subunit 11-2 pseudogene 8 (TRMT112P8).